From the Merck Manuals Professional Edition,
Hydroxychloroquine (HCQS) 200 mg also known as Plaquenil has been used for
decades to treat rheumatoid arthritis and other autoimmune diseases such as
lupus and sarcoidosis. It was released on the market in 1956 with Bayer
Pharmaceuticals being the original producer of it. This medication or drug,
HCQS, is also an anti-malarial drug used to cure acute malaria infections.
What is HCQS?
Hydroxychloroquine, also known as HCQS, is a medication that
is used to treat the symptoms of chronic inflammatory diseases like systemic
lupus erythematosus and rheumatoid arthritis. In addition, this drug has been
shown to be effective in treating the symptoms of certain forms of malaria and
toxoplasmosis. However, there are some side effects associated with HCQS that
can range from mild to life-threatening. These include dizziness and an
increased risk of seizures. It is important to weigh the potential benefits
against the possible risks before taking this medication.
How does it work?
COVID-19 is a virus that affects the brain and causes
symptoms such as paralysis, seizures, headaches, and difficulty walking. In an
effort to find a cure to this virus, doctors have been looking for treatments.
One of these treatments is Hydroxychloroquine (HCQS). HCQS is a drug that has
been around since the 1960s and was approved by the FDA in 1994 to treat
rheumatoid arthritis. It works by reducing inflammation and slowing down the
body's immune system response to reduce joint pain and stiffness.
What are the side effects?
Side effects of HCQS are not common, but some people may
experience GI upset and diarrhea. Other side effects that have been reported
include dizziness, headache, fever, anorexia, nausea and vomiting. In rare
cases erythema multiforme as well as hypersensitivity reactions including rash
with fever and eosinophilia have been reported. Serious adverse events are very
uncommon with this medication.
Who should take it?
COVID-19 is a neurological disorder that causes chronic,
debilitating headaches. HCQS is an anti-malarial drug that has been shown to
reduce the frequency of headaches by up to 60%. But does it work for everyone?
Let's break down the specifics.
Is it a cure for COVID-19?
Hydroxychloroquine is a drug commonly prescribed to treat
various forms of arthritis and psoriasis. However, it may also be an effective
treatment for chronic fatigue syndrome, also known as COVID-19. In fact, HCQS
has been used in clinical trials to study its effectiveness in treating the
condition. There are many symptoms of CFS that are similar to those seen with
rheumatoid arthritis and other conditions, such as fatigue and joint pain; all
of which can be alleviated by HCQS. The most common side effects include
nausea, headache and dizziness but these typically subside within 2 weeks of
starting treatment.